{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:44:42Z","timestamp":1782920682201,"version":"3.54.5"},"reference-count":114,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>\n                    Heart failure (HF) is a global health crisis and remains a leading cause of morbidity, mortality, and healthcare expenditure despite substantial advances in pharmacological and device-based therapy. Impaired sarcoplasmic reticulum (SR) Ca\n                    <jats:sup>2+<\/jats:sup>\n                    cycling, driven largely by reduced activity of the SR Ca\n                    <jats:sup>2+<\/jats:sup>\n                    -ATPase 2a (SERCA2a), is a hallmark molecular feature of the failing myocardium. The SERCA2a-phospholamban (PLN) regulatory axis has long attracted therapeutic interest, however, clinical translation of SERCA2a gene therapy has been inconsistent, and strategies targeting PLN raise safety concerns, as complete PLN loss is lethal in humans. Dwarf Open Reading Frame (DWORF; gene name\n                    <jats:italic>STRIT1<\/jats:italic>\n                    ) is a 34\u201335 amino acid single-pass transmembrane microprotein and the only known endogenous positive regulator of SERCA2a within the SERCA-regulin family. In contrast to inhibitory regulins including PLN, sarcolipin (SLN), myoregulin (MLN), endoregulin (ELN), and another-regulin (ALN), DWORF enhances SERCA2a activity by increasing its catalytic turnover and displacing PLN from a shared regulatory binding site, thereby promoting Ca\n                    <jats:sup>2+<\/jats:sup>\n                    reuptake into the SR. Structurally, a proline at position 15 (Pro15) introduces a critical kink that separates DWORF\u2019s N-terminal amphipathic helix from its C-terminal transmembrane domain, with disruption of this feature abolishing DWORF\u2019s activating properties and converting DWORF into a PLN-like inhibitor. DWORF expression is restricted to ventricular myocardium and slow-twitch skeletal muscle, increases postnatally with cardiac maturation, and is consistently reduced in heart failure models. Across multiple preclinical models including dilated cardiomyopathy, Duchenne muscular dystrophy cardiomyopathy, pressure overload-induced heart failure, PLN-R14del cardiomyopathy, and ischemia-reperfusion injury, DWORF gene therapy improves Ca\n                    <jats:sup>2+<\/jats:sup>\n                    handling, reduces fibrosis, and restores mitochondrial energetics, even when administered after established disease. The compact coding sequence of DWORF is ideally suited for adeno-associated virus delivery, enabling efficient packaging and potential multiplexing strategies. Together, these features position DWORF as a mechanistically distinct and physiologically robust strategy for enhancing SERCA2a function. This review summarizes the molecular mechanisms underlying DWORF activity, evaluates preclinical therapeutic evidence, and discusses key translational considerations, including species differences, safety, and remaining knowledge gaps that must be addressed to advance DWORF-based therapy toward clinical application in heart failure.\n                  <\/jats:p>","DOI":"10.3389\/fcell.2026.1864847","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:50:33Z","timestamp":1782917433000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Microprotein, macro-effect: DWORF as a therapeutic strategy in heart failure"],"prefix":"10.3389","volume":"14","author":[{"given":"Joseph P.","family":"Verry","sequence":"first","affiliation":[{"name":"The Heart Institute, Division of Molecular Cardiovascular Biology, Cincinnati Children\u2019s Hospital Medical Center","place":["Cincinnati, OH, United States"]},{"name":"Medical Scientist Training Program, University of Cincinnati College of Medicine","place":["Cincinnati, OH, United States"]},{"name":"Pathobiology and Molecular Medicine Graduate Program, University of Cincinnati College of Medicine","place":["Cincinnati, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Makarewich","sequence":"additional","affiliation":[{"name":"The Heart Institute, Division of Molecular Cardiovascular Biology, Cincinnati Children\u2019s Hospital Medical Center","place":["Cincinnati, OH, United States"]},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine","place":["Cincinnati, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1113\/JP270953","article-title":"Cardioprotection in ischaemia-reperfusion injury: novel mechanisms and clinical translation","volume":"593","author":"Altamirano","year":"2015","journal-title":"J. Physiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cell.2015.01.009","article-title":"A micropeptide encoded by a putative long noncoding RNA regulates muscle performance","volume":"160","author":"Anderson","year":"2015","journal-title":"Cell."},{"key":"B3","doi-asserted-by":"publisher","first-page":"ra119","DOI":"10.1126\/scisignal.aaj1460","article-title":"Widespread control of calcium signaling by a family of SERCA-Inhibiting micropeptides","volume":"9","author":"Anderson","year":"2016","journal-title":"Sci. Signal"},{"key":"B4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/s0092-8674(00)81878-4","article-title":"MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure","volume":"88","author":"Arber","year":"1997","journal-title":"Cell."},{"key":"B5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s10020-025-01242-1","article-title":"AEOL-Induced NRF2 activation and DWORF overexpression mitigate myocardial I\/R injury","volume":"31","author":"Asensio-Lopez","year":"2025","journal-title":"Mol. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.cmet.2025.03.009","article-title":"Identification of a molecular resistor that controls UCP1-independent Ca(2+) cycling thermogenesis in adipose tissue","volume":"37","author":"Auger","year":"2025","journal-title":"Cell. Metab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3390\/biom14060675","article-title":"Perimenopause decreases SERCA2a activity in the hearts of a mouse model of ovarian failure","volume":"14","author":"Barry","year":"2024","journal-title":"Biomolecules"},{"key":"B8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation\u2013contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1152\/physiol.00019.2006","article-title":"Altered cardiac myocyte ca regulation in heart failure","volume":"21","author":"Bers","year":"2006","journal-title":"Physiol. (Bethesda)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.yjmcc.2009.07.014","article-title":"Threonine-5 at the N-terminus can modulate sarcolipin function in cardiac myocytes","volume":"47","author":"Bhupathy","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"102910","DOI":"10.1016\/j.ceca.2024.102910","article-title":"Phosphorylation of phospholamban promotes SERCA2a activation by dwarf open reading frame (DWORF)","volume":"121","author":"Bovo","year":"2024","journal-title":"Cell. Calcium"},{"key":"B12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cardfail.2024.07.001","article-title":"HF STATS 2024: heart failure epidemiology and outcomes statistics an updated 2024 report from the heart failure society of America","volume":"31","author":"Bozkurt","year":"2025","journal-title":"J. Card. Fail"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3791\/63841","article-title":"An integrated approach for microprotein identification and sequence analysis","author":"Brito-Estrada","year":"2022","journal-title":"J. Vis. Exp."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/circresaha.125.326550","article-title":"DWORF gene therapy improves cardiac calcium handling and mitochondrial function","volume":"137","author":"Brito-Estrada","year":"2025","journal-title":"Circ. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"12129","DOI":"10.1074\/jbc.275.16.12129","article-title":"Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban","volume":"275","author":"Brittsan","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"106069","DOI":"10.1016\/j.isci.2023.106069","article-title":"Proteoforms expand the world of microproteins and short open reading frame-encoded peptides","volume":"26","author":"Cassidy","year":"2023","journal-title":"iScience"},{"key":"B17","doi-asserted-by":"publisher","first-page":"26596","DOI":"10.1074\/jbc.M112.382713","article-title":"Lethal, hereditary mutants of phospholamban elude phosphorylation by protein kinase A","volume":"287","author":"Ceholski","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41586-022-04817-8","article-title":"Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy","volume":"608","author":"Chaffin","year":"2022","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"C382","DOI":"10.1152\/ajpcell.00198.2021","article-title":"Role of SERCA and sarcolipin in adaptive muscle remodeling","volume":"322","author":"Chambers","year":"2022","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/s41401-025-01711-7","article-title":"PLN-L31A\/I40A for the treatment of inherited heart disease caused by PLN-R14del mutations","volume":"47","author":"Chen","year":"2026","journal-title":"Acta Pharmacol. Sin."},{"key":"B22","doi-asserted-by":"publisher","first-page":"102060","DOI":"10.1016\/j.jbc.2022.102060","article-title":"Inhibitory and stimulatory micropeptides preferentially bind to different conformations of the cardiac calcium pump","volume":"298","author":"Cleary","year":"2022","journal-title":"J. Biol. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1021\/bi961955q","article-title":"Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers","volume":"36","author":"Cornea","year":"1997","journal-title":"Biochemistry"},{"key":"B24","doi-asserted-by":"publisher","first-page":"103608","DOI":"10.1016\/j.semcdb.2025.103608","article-title":"Emerging roles for microproteins as critical regulators of endoplasmic reticulum function and cellular homeostasis","volume":"170","author":"Coughlin","year":"2025","journal-title":"Semin. Cell. Dev. Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"103000","DOI":"10.1016\/j.ceca.2025.103000","article-title":"Rapid quantification of intracellular calcium stores reveals effects of membrane micropeptides on SERCA function","volume":"126","author":"Cunningham","year":"2025","journal-title":"Cell. Calcium"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1179546816686061","DOI":"10.1177\/1179546816686061","article-title":"Species-dependent mechanisms of cardiac arrhythmia: a cellular focus","volume":"11","author":"Edwards","year":"2017","journal-title":"Clin. Med. Insights Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"9819","DOI":"10.1038\/s41598-020-66656-9","article-title":"The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapy","volume":"10","author":"Eijgenraam","year":"2020","journal-title":"Sci. Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e008532","DOI":"10.1161\/circheartfailure.121.008532","article-title":"Protein aggregation is an early manifestation of phospholamban p.(Arg14del)-Related cardiomyopathy: development of PLN-R14del-Related cardiomyopathy","volume":"14","author":"Eijgenraam","year":"2021","journal-title":"Circ. Heart Fail"},{"key":"B30","doi-asserted-by":"publisher","first-page":"121160","DOI":"10.1016\/j.lfs.2022.121160","article-title":"SERCA2a directs the cardioprotective role of nano-emulsion curcumin against PM(2.5)-induced cardiac injury in rats by prohibiting PERK-eIF2alpha pathway","volume":"311","author":"El Tabaa","year":"2022","journal-title":"Life Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1161\/circresaha.125.327249","article-title":"Unlocking mitochondrial potential: DWORF to the rescue in heart failure","volume":"137","author":"Elbatreek","year":"2025","journal-title":"Circ. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"107925","DOI":"10.1016\/j.celrep.2020.107925","article-title":"Metabolic maturation media improve physiological function of human iPSC-Derived cardiomyocytes","volume":"32","author":"Feyen","year":"2020","journal-title":"Cell. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e65545","DOI":"10.7554\/elife.65545","article-title":"Dwarf open reading frame (DWORF) is a direct activator of the sarcoplasmic reticulum calcium pump SERCA","volume":"10","author":"Fisher","year":"2021","journal-title":"Elife"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1021\/acs.biochem.5c00305","article-title":"Structural elements of dwarf open reading frame required for activation of the sarco-endoplasmic reticulum calcium pump","volume":"64","author":"Fisher","year":"2025","journal-title":"Biochemistry"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1093\/cvr\/cvad037","article-title":"Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation","volume":"119","author":"Funk","year":"2023","journal-title":"Cardiovasc Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"dmm052285","DOI":"10.1242\/dmm.052285","article-title":"DWORF expression is reduced in a large animal model of Duchenne muscular dystrophy","volume":"18","author":"Gibson","year":"2025","journal-title":"Dis. Model. Mech."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a035428","article-title":"Calcium signaling in cardiomyocyte function","volume":"12","author":"Gilbert","year":"2020","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1021\/bi2018909","article-title":"Role of mitochondrial Ca2+ in the regulation of cellular energetics","volume":"51","author":"Glancy","year":"2012","journal-title":"Biochemistry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jmb.2010.11.014","article-title":"Phosphorylation and mutation of phospholamban alter physical interactions with the sarcoplasmic reticulum calcium pump","volume":"405","author":"Glaves","year":"2011","journal-title":"J. Mol. Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cmet.2015.01.005","article-title":"Altered myocardial calcium cycling and energetics in heart failure--a rational approach for disease treatment","volume":"21","author":"Gorski","year":"2015","journal-title":"Cell. Metab."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","article-title":"Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial","volume":"387","author":"Greenberg","year":"2016","journal-title":"Lancet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.yjmcc.2010.11.011","article-title":"Cardiac gene therapy with SERCA2a: from bench to bedside","volume":"50","author":"Gwathmey","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1172\/JCI17892","article-title":"Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human","volume":"111","author":"Haghighi","year":"2003","journal-title":"J. Clin. Investigation"},{"key":"B45","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.yjmcc.2014.10.005","article-title":"Phospholamban interactome in cardiac contractility and survival: a new vision of an old friend","volume":"77","author":"Haghighi","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/01.res.75.3.434","article-title":"Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium","volume":"75","author":"Hasenfuss","year":"1994","journal-title":"Circ. Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"106781","DOI":"10.1016\/j.isci.2023.106781","article-title":"Microproteins: overlooked regulators of physiology and disease","volume":"26","author":"Hassel","year":"2023","journal-title":"iScience"},{"key":"B48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.yjmcc.2024.10.008","article-title":"Another-regulin regulates cardiomyocyte calcium handling via integration of neuroendocrine signaling with SERCA2a activity","volume":"197","author":"Hassel","year":"2024","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e876","DOI":"10.1161\/cir.0000000000001062","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"B111","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1038\/s41591-025-04011-z","article-title":"Cardiotropic AAV gene therapy for heart failure: a phase 1 trial","volume":"31","author":"Henry","year":"2025","journal-title":"Nat. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell."},{"key":"B51","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","article-title":"Calcium upregulation by percutaneous administration of gene therapy in cardiac disease, I. 2011. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure","volume":"124","author":"Jessup","year":"2011","journal-title":"Circulation"},{"key":"B52","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1038\/ncomms7955","article-title":"Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy","volume":"6","author":"Karakikes","year":"2015","journal-title":"Nat. Commun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s43856-025-00787-w","article-title":"AAV9-cBIN1 gene therapy rescues chronic heart failure due to ischemic cardiomyopathy in a canine model","volume":"5","author":"Khan","year":"2025","journal-title":"Commun. Med. (Lond)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12933-025-03023-w","article-title":"The SERCA-PLN-DWORF axis in cardiometabolic disease: mechanisms and therapeutic perspectives","volume":"25","author":"Kim","year":"2025","journal-title":"Cardiovasc Diabetol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"15061","DOI":"10.1074\/jbc.272.24.15061","article-title":"Phospholamban inhibitory function is activated by depolymerization","volume":"272","author":"Kimura","year":"1997","journal-title":"J. Biol. Chem."},{"key":"B56","doi-asserted-by":"publisher","first-page":"100460","DOI":"10.1016\/j.xhgg.2025.100460","article-title":"Common genetic modifiers influence cardiomyopathy susceptibility among the carriers of rare pathogenic variants","volume":"6","author":"Klasfeld","year":"2025","journal-title":"HGG Adv."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1161\/CIRCRESAHA.111.259754","article-title":"Modulation of cardiac contractility by the phospholamban\/SERCA2a regulatome","volume":"110","author":"Kranias","year":"2012","journal-title":"Circ. Res."},{"key":"B57","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-031-08309-9_1","article-title":"Calcium-dependent signaling in cardiac myocytes","volume-title":"Cardiovascular Signaling in Health and Disease","author":"Ko","year":"2022"},{"key":"B58","doi-asserted-by":"publisher","first-page":"100412","DOI":"10.1016\/j.jbc.2021.100412","article-title":"The transmembrane peptide DWORF activates SERCA2a via dual mechanisms","volume":"296","author":"Li","year":"2021","journal-title":"J. Biol. Chem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","article-title":"Cells of the adult human heart","volume":"588","author":"Litvinukova","year":"2020","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1161\/CIRCRESAHA.113.301651","article-title":"Mechanisms of altered Ca(2)(+) handling in heart failure","volume":"113","author":"Luo","year":"2013","journal-title":"Circ. Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/01.RES.75.3.401","article-title":"Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation","volume":"75","author":"Luo","year":"1994","journal-title":"Circ. Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e012661","DOI":"10.1161\/circheartfailure.124.012661","article-title":"Unraveling the pathophysiological mechanisms of phospholamban R14del cardiomyopathy: a comprehensive overview","volume":"18","author":"Maas","year":"2025","journal-title":"Circ. Heart Fail."},{"key":"B62","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrm1151","article-title":"Phospholamban: a crucial regulator of cardiac contractility","volume":"4","author":"Maclennan","year":"2003","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1126\/science.1238802","article-title":"Conserved regulation of cardiac calcium uptake by peptides encoded in small open reading frames","volume":"341","author":"Magny","year":"2013","journal-title":"Science"},{"key":"B64","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.tcb.2017.04.006","article-title":"Mining for micropeptides","volume":"27","author":"Makarewich","year":"2017","journal-title":"Trends Cell. Biol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e38319","DOI":"10.7554\/eLife.38319","article-title":"The DWORF micropeptide enhances contractility and prevents heart failure in a mouse model of dilated cardiomyopathy","volume":"7","author":"Makarewich","year":"2018","journal-title":"Elife"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.120.317156","article-title":"Gene therapy with the DWORF micropeptide attenuates cardiomyopathy in mice","volume":"127","author":"Makarewich","year":"2020","journal-title":"Circ. Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e14082","DOI":"10.1111\/apha.14082","article-title":"Early consequences of the phospholamban mutation PLN-R14del(+\/-) in a transgenic mouse model","volume":"240","author":"Maniezzi","year":"2024","journal-title":"Acta Physiol. (Oxf)"},{"key":"B68","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/s0092-8674(00)80847-8","article-title":"PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (Ryanodine receptor): Defective regulation in failing hearts","volume":"101","author":"Marx","year":"2000","journal-title":"Cell."},{"key":"B69","doi-asserted-by":"publisher","first-page":"170192","DOI":"10.1016\/j.peptides.2019.170192","article-title":"Cardiovascular effects of DWORF (dwarf open reading frame) peptide in normal and ischaemia\/reperfused isolated rat hearts","volume":"124","author":"Mbikou","year":"2020","journal-title":"Peptides"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/nejmoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"Mcmurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.pharmthera.2013.10.007","article-title":"Small and large animal models in cardiac contraction research: advantages and disadvantages","volume":"141","author":"Milani-Nejad","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"B72","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/s0092-8674(00)81662-1","article-title":"Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy","volume":"99","author":"Minamisawa","year":"1999","journal-title":"Cell."},{"key":"B73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"B74","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/s0092-8674(00)81573-1","article-title":"A calcineurin-dependent transcriptional pathway for cardiac hypertrophy","volume":"93","author":"Molkentin","year":"1998","journal-title":"Cell."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e027480","DOI":"10.1161\/jaha.122.027480","article-title":"Dwarf open reading frame (DWORF) gene therapy ameliorated Duchenne muscular dystrophy cardiomyopathy in aged mdx mice","volume":"12","author":"Morales","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"B76","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1186\/s12891-024-07927-8","article-title":"Transcriptional changes of genes encoding sarcoplasmic reticulum calcium binding and up-taking proteins in normal and Duchenne muscular dystrophy dogs","volume":"25","author":"Morales","year":"2024","journal-title":"BMC Musculoskelet. Disord."},{"key":"B77","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1126\/science.aad4076","article-title":"A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3389\/fphys.2020.01068","article-title":"Targeting Ca(2 +) handling proteins for the treatment of heart failure and arrhythmias","volume":"11","author":"Njegic","year":"2020","journal-title":"Front. Physiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"157","DOI":"10.18553\/jmcp.2022.28.2.157","article-title":"Burden of hospitalization for heart failure in the United States: a systematic literature review","volume":"28","author":"Osenenko","year":"2022","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"B80","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/cvr\/cvm056","article-title":"Regulation of sarcoplasmic reticulum Ca2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology","volume":"77","author":"Periasamy","year":"2008","journal-title":"Cardiovasc Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.bpj.2022.12.014","article-title":"Micropeptide hetero-oligomerization adds complexity to the calcium pump regulatory network","volume":"122","author":"Phillips","year":"2023","journal-title":"Biophys. J."},{"key":"B82","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2174\/138945011795378559","article-title":"Triple threat: the Na+\/Ca2+ exchanger in the pathophysiology of cardiac arrhythmia, ischemia and heart failure","volume":"12","author":"Pott","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"B83","doi-asserted-by":"publisher","first-page":"8891","DOI":"10.3390\/ijms22168891","article-title":"Nothing regular about the regulins: distinct functional properties of SERCA transmembrane peptide regulatory subunits","volume":"22","author":"Rathod","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.str.2021.11.003","article-title":"A kink in DWORF helical structure controls the activation of the sarcoplasmic reticulum Ca(2+)-ATPase","volume":"30","author":"Reddy","year":"2022","journal-title":"Structure"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e55353","DOI":"10.3791\/55353","article-title":"Murine left anterior descending (lad) coronary artery ligation: an improved and simplified model for myocardial infarction","volume":"122","author":"Reichert","year":"2017","journal-title":"J. Vis. Exp."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00021.2015","article-title":"Mechanistic pathways of sex differences in cardiovascular disease","volume":"97","author":"Regitz-Zagrosek","year":"2017","journal-title":"Physiol. Rev."},{"key":"B86","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ijcard.2016.10.021","article-title":"Junctophilin-2 gene therapy rescues heart failure by normalizing RyR2-mediated Ca(2+) release","volume":"225","author":"Reynolds","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"5844","DOI":"10.1038\/s41598-019-42209-7","article-title":"Distinct phenotypes induced by three degrees of transverse aortic constriction in mice","volume":"9","author":"Richards","year":"2019","journal-title":"Sci. Rep."},{"key":"B88","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41586-018-0016-3","article-title":"Advanced maturation of human cardiac tissue grown from pluripotent stem cells","volume":"556","author":"Ronaldson-Bouchard","year":"2018","journal-title":"Nature"},{"key":"B89","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1006\/jmbi.1999.3489","article-title":"The GxxxG motif: a framework for transmembrane helix-helix association","volume":"296","author":"Russ","year":"2000","journal-title":"J. Mol. Biol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bbrc.2023.01.041","article-title":"Interaction of DWORF with SERCA and PLB as determined by EPR spectroscopy","volume":"645","author":"Rustad","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B91","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00395-022-00973-0","article-title":"Electrophysiological and calcium-handling development during long-term culture of human-induced pluripotent stem cell-derived cardiomyocytes","volume":"118","author":"Seibertz","year":"2023","journal-title":"Basic Res. Cardiol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10741-025-10487-1","article-title":"SERCA2a dysfunction in the pathophysiology of heart failure with preserved ejection fraction: a direct role is yet to be established","volume":"30","author":"Shooshtarian","year":"2025","journal-title":"Heart Fail Rev."},{"key":"B93","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1016\/j.jmb.2019.07.037","article-title":"Newly discovered micropeptide regulators of SERCA form oligomers but bind to the pump as monomers","volume":"431","author":"Singh","year":"2019","journal-title":"J. Mol. Biol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"7392","DOI":"10.3390\/ijms22147392","article-title":"Calcium and heart failure: how did we get here and where are we going?","volume":"22","author":"Siri-Angkul","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"EMBJ2018100020","DOI":"10.15252\/embj.2018100020","article-title":"Structures of the heart specific SERCA2a Ca(2+)-ATPase","volume":"38","author":"Sitsel","year":"2019","journal-title":"EMBO J."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1161\/circresaha.123.323304","article-title":"DWORF extends life span in a PLN-R14del cardiomyopathy mouse model by reducing abnormal sarcoplasmic reticulum clusters","volume":"133","author":"Stege","year":"2023","journal-title":"Circ. Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.jacbts.2024.02.017","article-title":"Reassessing the mechanisms of PLN-R14del cardiomyopathy","volume":"9","author":"Stege","year":"","journal-title":"JACC Basic Transl. Sci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"H870","DOI":"10.1152\/ajpheart.00741.2023","article-title":"Deletion of DWORF does not affect cardiac function in aging and in PLN-R14del cardiomyopathy","volume":"326","author":"Stege","year":"","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species","volume":"184","author":"Tabebordbar","year":"2021","journal-title":"Cell."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1161\/01.CIR.0000129233.51320.92","article-title":"Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy","volume":"109","author":"Terracciano","year":"2004","journal-title":"Circulation"},{"key":"B101","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nature00944","article-title":"Structural changes in the calcium pump accompanying the dissociation of calcium","volume":"418","author":"Toyoshima","year":"2002","journal-title":"Nature"},{"key":"B102","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1021\/bi047878d","article-title":"The effects of mutation on the regulatory properties of phospholamban in Co-Reconstituted membranes","volume":"44","author":"Trieber","year":"2005","journal-title":"Biochemistry"},{"key":"B103","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/jvim.15425","article-title":"Coding sequences of sarcoplasmic reticulum calcium ATPase regulatory peptides and expression of calcium regulatory genes in recurrent exertional rhabdomyolysis","volume":"33","author":"Valberg","year":"2019","journal-title":"J. Vet. Intern Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"108972","DOI":"10.1016\/j.isci.2024.108972","article-title":"No country for old methods: new tools for studying microproteins","volume":"27","author":"Valdivia-Francia","year":"2024","journal-title":"iScience"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1093\/cvr\/cvy208","article-title":"Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential","volume":"114","author":"van Mil","year":"2018","journal-title":"Cardiovasc Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1042\/BJ20050068","article-title":"Sarcolipin and phospholamban mRNA and protein expression in cardiac and skeletal muscle of different species","volume":"389","author":"Vangheluwe","year":"2005","journal-title":"Biochem. J."},{"key":"B107","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1161\/01.res.0000109415.17511.18","article-title":"Calcineurin\/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy","volume":"94","author":"Wilkins","year":"2004","journal-title":"Circulation Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/mt.2015.158","article-title":"Gene therapy for heart failure: back to the bench","volume":"23","author":"Yla-Herttuala","year":"2015","journal-title":"Mol. Ther."},{"key":"B109","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10741-019-09873-3","article-title":"SERCA2a: a key protein in the Ca(2+) cycle of the heart failure","volume":"25","author":"Zhihao","year":"2020","journal-title":"Heart Fail Rev."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1864847\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:50:34Z","timestamp":1782917434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1864847\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":114,"alternative-id":["10.3389\/fcell.2026.1864847"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1864847","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"1864847"}}